BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Shanshan Wang, Ting Lei, Man Zhang, Ferenc Gallyas. The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder CancerPLOS ONE 2016; 11(7): e0157759 doi: 10.1371/journal.pone.0157759
2
Martins Ekor, Adesina O. Odewabi, Oluwafemi E. Kale, Omolola A. Adesanoye, Titilayo O. Bamidele. Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride–associated hepatotoxicity in ratsDrug and Chemical Toxicology 2013; 36(1): 1 doi: 10.3109/01480545.2011.642380
3
Daniel J. Luther, Vahagn Ohanyan, Patricia E. Shamhart, Cheryl M. Hodnichak, Hamayak Sisakian, Tristan D. Booth, J. Gary Meszaros, Anupam Bishayee. Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinomaInvestigational New Drugs 2011; 29(2): 380 doi: 10.1007/s10637-009-9332-7
4
Yuko Takami, Susumu Eguchi, Masaki Tateishi, Tomoki Ryu, Kazuhiro Mikagi, Yoshiyuki Wada, Hideki Saitsu. A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatmentHepatology International 2016; 10(5): 799 doi: 10.1007/s12072-016-9704-y
5
Yuan Cao, Ming Zhao, Yue Zhu, Zhen-Hua Zhu, Lukas Oberer, Jin-Ao Duan. Diselaginellin B, an Unusual Dimeric Molecule from Selaginella pulvinata, Inhibited Metastasis and Induced Apoptosis of SMMC-7721 Human Hepatocellular Carcinoma CellsJournal of Natural Products 2017; 80(12): 3151 doi: 10.1021/acs.jnatprod.7b00404
6
Lydia Giannitrapani, Maurizio Soresi, Sabrina Ingrao, Emanuele La Spada, Onofrio Vuturo, Ada Maria Florena, Melchiorre Cervello, Giuseppe Montalto. Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis CEuropean Journal of Gastroenterology & Hepatology 2007; 19(11): 927 doi: 10.1097/MEG.0b013e3282f01e91
7
Dingbo Shi, Xiangsheng Xiao, Yun Tian, Lijun Qin, Fangyun Xie, Rui Sun, Jingshu Wang, Wenbin Li, Tianze Liu, Yao Xiao, Wendan Yu, Wei Guo, Yuqing Xiong, Huijuan Qiu, Tiebang Kang, Wenlin Huang, Chong Zhao, Wuguo Deng. Activating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growthOncotarget 2015; 6(7): 5005 doi: 10.18632/oncotarget.3215
8
Nelson Alexandre Kretzmann, Eduardo Chiela, Ursula Matte, Norma Marroni, Claudio Augusto Marroni. N-acetylcysteine improves antitumoural response of Interferon alpha by NF-kB downregulation in liver cancer cellsComparative Hepatology 2012; 11(1) doi: 10.1186/1476-5926-11-4
9
Mudan Ren, Eileen McGowan, Yarui Li, Xiaofeng Zhu, Xinlan Lu, Zhanfang Zhu, Yiguang Lin, Shuixiang He. Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of ActionFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00623
10
Hitomi Hayashi, Eriko Taniai, Reiko Morita, Atsunori Yafune, Kazuhiko Suzuki, Makoto Shibutani, Kunitoshi Mitsumori. Threshold dose of liver tumor promoting effect of β-naphthoflavone in ratsThe Journal of Toxicological Sciences 2012; 37(3): 517 doi: 10.2131/jts.37.517
11
Fei Yu, Kai Li, Suning Chen, Yunpeng Liu, Yan Li. Pseudolaric Acid B Circumvents Multidrug Resistance Phenotype in Human Gastric Cancer SGC7901/ADR Cells by Downregulating Cox-2 and P-gp ExpressionCell Biochemistry and Biophysics 2015; 71(1): 119 doi: 10.1007/s12013-014-0170-7
12
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_186-1
13
Antonella Cusimano, Daniele Balasus, Antonina Azzolina, Giuseppa Augello, Maria R. Emma, Caterina Di Sano, Roberto Gramignoli, Stephen C. Strom, James A. Mccubrey, Giuseppe Montalto, Melchiorre Cervello. Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generationInternational Journal of Oncology 2017; 51(2): 533 doi: 10.3892/ijo.2017.4049
14
Melchiorre Cervello, Dimcho Bachvarov, Nadia Lampiasi, Antonella Cusimano, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto, Manlio Vinciguerra. Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer CellsPLoS ONE 2013; 8(6): e65569 doi: 10.1371/journal.pone.0065569
15
Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum, Erik A. Rauws, B.W. Marcel Spanier, Alexander C. Poen, Karin M. van Nieuwkerk, Joost P. Drenth, Ben J. Witteman, Hans A. Tuynman, Anton H. Naber, Paul J. Kingma, Henk R. van Buuren, Bart van Hoek, Frank P. Vleggaar, Nan van Geloven, Ulrich Beuers, Cyriel Y. Ponsioen. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitisHepatology 2013; 58(6): 2045 doi: 10.1002/hep.26565
16
Ş. Küçükgüzel, İnci Coşkun, Sevil Aydın, Göknur Aktay, Şule Gürsoy, Özge Çevik, Özlem Özakpınar, Derya Özsavcı, Azize Şener, Neerja Kaushik-Basu, Amartya Basu, Tanaji Talele. Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant, Anticancer and Anti-HCV AgentsMolecules 2013; 18(3): 3595 doi: 10.3390/molecules18033595
17
Yu Sun, Jie Chen, Basil Rigas. Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell deathCarcinogenesis 2009; 30(1): 93 doi: 10.1093/carcin/bgn242
18
Isabel Fabregat. Dysregulation of apoptosis in hepatocellular carcinoma cellsWorld Journal of Gastroenterology 2009; 15(5): 513-520 doi: 10.3748/wjg.15.513
19
Jennifer K. Mulligan, Steven A. Rosenzweig, M. Rita I. Young. Tumor Secretion of VEGF Induces Endothelial Cells to Suppress T cell Functions Through the Production of PGE2Journal of Immunotherapy 2010; 33(2): 126 doi: 10.1097/CJI.0b013e3181b91c9c
20
Anupam Bishayee. Inflammation and CancerAdvances in Experimental Medicine and Biology 2014; 816: 401 doi: 10.1007/978-3-0348-0837-8_16
21
Andrea J. Moreira, Graziella Rodrigues, Silvia Bona, Carlos Thadeu Cerski, Claudio A. Marroni, Jose L. Mauriz, Javier González-Gallego, Norma P. Marroni. Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in ratsToxicology Reports 2015; 2: 333 doi: 10.1016/j.toxrep.2014.11.015
22
Tian-Huei Chu, Hoi-Hung Chan, Hsiao-Mei Kuo, Li-Fen Liu, Tsung-Hui Hu, Cheuk-Kwan Sun, Mei-Lang Kung, Shih-Wei Lin, E-Ming Wang, Yi-Ling Ma, Kwan-Hung Cheng, Kwok Hung Lai, Zhi-Hong Wen, Ping-I Hsu, Ming-Hong Tai. Celecoxib suppresses hepatoma stemness and progression by up-regulating PTENOncotarget 2014; 5(6): 1475 doi: 10.18632/oncotarget.1745
23
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular CarcinomaThe Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 2008; 291(6): 721 doi: 10.1002/ar.20668
24
Ola M Tork, Eman F Khaleel, Omnia M Abdelmaqsoud. Altered Cell to Cell Communication, Autophagy and Mitochondrial Dysfunction in a Model of Hepatocellular Carcinoma: Potential Protective Effects of Curcumin and Stem Cell TherapyAsian Pacific Journal of Cancer Prevention 2016; 16(18): 8271 doi: 10.7314/APJCP.2015.16.18.8271
25
Jinghua Duan, Yangde Zhang, Shiwei Han, Yuxiang Chen, Bo Li, Mingmei Liao, Wei Chen, Xingming Deng, Jinfeng Zhao, Boyun Huang. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticlesInternational Journal of Pharmaceutics 2010; 400(1-2): 211 doi: 10.1016/j.ijpharm.2010.08.033
26
Hitomi Hayashi, Eriko Taniai, Reiko Morita, Masahiro Hayashi, Daichi Nakamura, Atsushi Wakita, Kazuhiko Suzuki, Makoto Shibutani, Kunitoshi Mitsumori. Enhanced liver tumor promotion but not liver initiation activity in rats subjected to combined administration of omeprazole and ^|^beta;-naphthoflavoneThe Journal of Toxicological Sciences 2012; 37(5): 969 doi: 10.2131/jts.37.969
27
Nasimudeen R. Jabir, Saheem Ahmad, Shams Tabrez. An insight on the association of glycation with hepatocellular carcinomaSeminars in Cancer Biology 2018; 49: 56 doi: 10.1016/j.semcancer.2017.06.005
28
Larissa Widholzer Galant, Ângelo Alves de Mattos, Eduardo Menti, Fabiana Borba Valiatti, Ângelo Zambam de Mattos, Marilene Porawski, Antônio Hartmann, Cláudia Ramos Rhoden. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in ratsAnnals of Hepatology 2013; 12(3): 425 doi: 10.1016/S1665-2681(19)31005-1
29
Anupam Bishayee, Roslin J. Thoppil, Altaf S. Darvesh, Vahagn Ohanyan, J. Gary Meszaros, Deepak Bhatia. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesisThe Journal of Nutritional Biochemistry 2013; 24(1): 178 doi: 10.1016/j.jnutbio.2012.04.009
30
Susan Kralian, Brian I. Carr. Hepatocellular Carcinoma2016; : 513 doi: 10.1007/978-3-319-34214-6_34
31
Xu Huang, Xiaoping Zhang, Benyamin Farahvash, Aria F. Olumi. Novel Targeted Pro-Apoptotic Agents for the Treatment of Prostate CancerJournal of Urology 2007; 178(5): 1846 doi: 10.1016/j.juro.2007.06.039
32
Chun-Chieh Yeh, Jaw-Town Lin, Long-Bin Jeng, Hsiu J. Ho, Horng-Ren Yang, Ming-Shiang Wu, Ken N. Kuo, Chun-Ying Wu. Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver ResectionAnnals of Surgery 2015; 261(3): 521 doi: 10.1097/SLA.0000000000000746
33
Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Kohji Moriishi. Inhibitory effect of presenilin inhibitor LY411575 on maturation of hepatitis C virus core protein, production of the viral particle and expression of host proteins involved in pathogenicityMicrobiology and Immunology 2016; 60(11): 740 doi: 10.1111/1348-0421.12448
34
Eun-Ji Kim, Gyeoung-Jin Kang, Jung-Il Kang, Hye-Jin Boo, Jin Won Hyun, Young Sang Koh, Weon-Young Chang, Young Ree Kim, Jung-Mi Kwon, Young Hee Maeng, Eun-Sook Yoo, Chang Hoon Lee, Hee-Kyoung Kang. Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cellsOncotarget 2018; 9(28): 19911 doi: 10.18632/oncotarget.24952
35
Thomas W. Kensler, John D. Groopman, Patricia A. Egner, Alvaro Muñoz, GengSun Qian, JianGuo Chen. Primary Liver Cancer2012; : 339 doi: 10.1007/978-3-642-28702-2_11
36
Chun-Chieh Wu, Sheau-Fang Yang, Wan-Tzu Chen, Hung-Pei Tsai, Chi-Wen Luo, Chee-Yin Chai, Hsin Ling Yin. Absence of CD66a expression is associated with high microvessel density and high histologic grade in hepatocellular carcinomaThe Kaohsiung Journal of Medical Sciences 2016; 32(6): 306 doi: 10.1016/j.kjms.2016.05.007
37
Manlio Vinciguerra, Michelangelo Foti. PTEN at the crossroad of metabolic diseases and cancer in the liverAnnals of Hepatology 2008; 7(3): 192 doi: 10.1016/S1665-2681(19)31848-4
38
Weiqi Hu, Weimin Xu, Yi Shi, Weijun Dai. lncRNA HOTAIR upregulates COX-2 expression to promote invasion and migration of nasopharyngeal carcinoma by interacting with miR-101Biochemical and Biophysical Research Communications 2018; 505(4): 1090 doi: 10.1016/j.bbrc.2018.09.190
39
Shanshan Wang, Qian Meng, Qing Xie, Man Zhang. Effect and mechanism of resveratrol on drug resistance in human bladder cancer cellsMolecular Medicine Reports 2017; 15(3): 1179 doi: 10.3892/mmr.2017.6111
40
D Lu, C Han, T Wu. 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1Oncogene 2014; 33(9): 1101 doi: 10.1038/onc.2013.69
41
Anupam Bishayee, Roslin J. Thoppil, Animesh Mandal, Altaf S. Darvesh, Vahagn Ohanyan, J. Gary Meszaros, Erzsébet Háznagy-Radnai, Judit Hohmann, Deepak Bhatia. Black currant phytoconstituents exert chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis by suppression of the inflammatory responseMolecular Carcinogenesis 2013; 52(4): 304 doi: 10.1002/mc.21860
42
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizonOncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
43
Lydia Giannitrapani, Sabrina Ingrao, Maurizio Soresi, Ada Maria Florena, Emanuele La Spada, Luigi Sandonato, Natale D'Alessandro, Melchiorre Cervello, Giuseppe Montalto. Cyclooxygenase-2 Expression in Chronic Liver Diseases and Hepatocellular CarcinomaAnnals of the New York Academy of Sciences 2009; 1155(1): 293 doi: 10.1111/j.1749-6632.2009.03698.x
44
Jeong Won Jang. Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitorThe Korean Journal of Hepatology 2008; 14(3): 305 doi: 10.3350/kjhep.2008.14.3.305
45
Shuhuai Wang, Xinmei Kang, Shouqiang Cao, Hui Cheng, Di Wang, Jingshu Geng. Calcineurin/NFATc1 Pathway Contributes to Cell Proliferation in Hepatocellular CarcinomaDigestive Diseases and Sciences 2012; 57(12): 3184 doi: 10.1007/s10620-012-2255-8
46
Maria Teresa Rizzo. Cyclooxygenase-2 in oncogenesisClinica Chimica Acta 2011; 412(9-10): 671 doi: 10.1016/j.cca.2010.12.026
47
Vikrant V. Sahasrabuddhe, Munira Z. Gunja, Barry I. Graubard, Britton Trabert, Lauren M. Schwartz, Yikyung Park, Albert R. Hollenbeck, Neal D. Freedman, Katherine A. McGlynn. Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular CarcinomaJNCI: Journal of the National Cancer Institute 2012; 104(23): 1808 doi: 10.1093/jnci/djs452
48
Anupam Bishayee, Abhijeet Waghray, Kendra F. Barnes, Thomas Mbimba, Deepak Bhatia, Malay Chatterjee, Altaf S. Darvesh. Suppression of the Inflammatory Cascade is Implicated in Resveratrol Chemoprevention of Experimental HepatocarcinogenesisPharmaceutical Research 2010; 27(6): 1080 doi: 10.1007/s11095-010-0144-4
49
Mohammed A. El-Magd, Yasser Mohamed, Eman S. El-Shetry, Shafika A. Elsayed, Maha Abo Gazia, Ghada A. Abdel-Aleem, Noha M. Shafik, Walied S. Abdo, Nabila I. El-Desouki, Mohamed A. Basyony. Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DEN-induced rat model of HCCBiomedicine & Pharmacotherapy 2019; 114: 108732 doi: 10.1016/j.biopha.2019.108732
50
Verónica G. Piazza, María E. Matzkin, Nadia S. Cicconi, Nadia V. Muia, Sofía Valquinta, Gregorio J. Mccallum, Giannina P. Micucci, Thomas Freund, Elsa Zotta, Lorena González, Mónica B. Frungieri, Yimin Fang, Andrzej Bartke, Ana I. Sotelo, Johanna G. Miquet. Exposure to growth hormone is associated with hepatic up-regulation of cPLA2α and COXMolecular and Cellular Endocrinology 2020; 509: 110802 doi: 10.1016/j.mce.2020.110802
51
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesisBiomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
52
Wei-Bing Li, Yang Li, Chen Yu, Yong-Ming He. Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR CellsEvidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/390812
53
Li-Jie Wang, Li Bai, Dan Su, Ting Zhang, Zhi-Yuan Mao. Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathwaysMolecular and Cellular Biochemistry 2013; 381(1-2): 173 doi: 10.1007/s11010-013-1700-0
54
Hyunjoo Lee, Joshua S. Trott, Shabirul Haque, Steven McCormick, Nicholas Chiorazzi, Patricia K. A. Mongini. A Cyclooxygenase-2/Prostaglandin E2Pathway Augments Activation-Induced Cytosine Deaminase Expression within Replicating Human B CellsThe Journal of Immunology 2010; 185(9): 5300 doi: 10.4049/jimmunol.1000574
55
Santanu Maji, Sabindra K Samal, Laxmipriya Pattanaik, Swagatika Panda, Bridget A. Quinn, Swadesh K. Das, Devanand Sarkar, Maurizio Pellecchia, Paul B. Fisher, Rupesh Dash. Mcl-1 is an important therapeutic target for oral squamous cell carcinomasOncotarget 2015; 6(18): 16623 doi: 10.18632/oncotarget.3932
56
Maria Grazia Refolo, Caterina Messa, Vito Guerra, Brian Irving Carr, Rosalba D’Alessandro. Inflammatory Mechanisms of HCC DevelopmentCancers 2020; 12(3): 641 doi: 10.3390/cancers12030641
57
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3443 doi: 10.1007/978-3-319-26956-6_186
58
Kyu-Hwa Lee, Seok-Chul Yang. Relation between Cyclooxygenase-2 and Polo-like Kinase-1 in Non-Small Cell Lung CancerTuberculosis and Respiratory Diseases 2009; 67(4): 303 doi: 10.4046/trd.2009.67.4.303
59
V. Sivaramakrishnan, S. Niranjali Devaraj. Morin regulates the expression of NF-κB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinomaChemico-Biological Interactions 2009; 180(3): 353 doi: 10.1016/j.cbi.2009.02.004
60
Magda Hamzawy, Laila Elsaid, Asmaa Shams, Laila Rashid, Soheir Mahfouz, Nivin Sharawy. Study of the Effects of Cyclooxygenase-2 Inhibitor on the Promotion of Hepatic Tumorigenesis in Rats Fed a High Fat DietJournal of Clinical and Experimental Hepatology 2015; 5(1): 14 doi: 10.1016/j.jceh.2014.12.010